middle.news
Starpharma and Genentech Forge $570M Cancer Therapy Partnership
8:58am on Monday 22nd of September, 2025 AEST
•
Biotechnology
Read Story
Starpharma and Genentech Forge $570M Cancer Therapy Partnership
8:58am on Monday 22nd of September, 2025 AEST
Key Points
Starpharma to develop dendrimer-drug conjugates with Genentech medicines
Upfront payment of USD 5.5 million and potential milestones up to USD 564 million
Exclusive worldwide license granted to Genentech for commercialization
Collaboration builds on three years of prior joint research
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Starpharma Holdings (ASX:SPL)
OPEN ARTICLE